ANL
ANL
Positions held
Your positionsANL isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-30 · Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations
2026-09-15 · 4.8x P B? Adlai Nortye Group (ANL) On Its AN4035 Trial Progress
2026-09-06 · These 2 ‘Monster Growth’ Stocks Aren’t Done Climbing, Say Analysts
2026-08-14 · Adlai Nortye Ltd. Reports Unaudited First Half 2026 Financial Results and Highlights Recent Operational Progress
2026-07-13 · Adlai Nortye Expands Scientific Advisory Board with Appointment of Two Leading Medical Oncologists
Price (daily)
Full chart · RSI · MACD · patterns